5 ESSENTIAL ELEMENTS FOR ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

In Phase A, contributors will get distinctive doses and schedules of oral ABBV-744 pill to discover Risk-free dosing regimen. Additional contributors might be enrolled for the recognized monotherapy dosign routine. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be specified as "increase-on" therapy. In Section C, participants w